Atlas Trials

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Clinical trial NCT02487550 · NOT_YET_RECRUITING

Trial details

NCT number
NCT02487550
Sponsor
The First People's Hospital of Changzhou
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Neoplasma
Start date
2015-08-01
Primary completion
2028-07-01
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.